In this episode of Industry Focus: Wild Card Wednesday, Dylan Lewis and Brian Feroldi take a deep dive into Semler Scientific (OTC: SMLR), LeMaitre Vascular (NASDAQ: LMAT), and Fulgent Genetics (NASDAQ: FLGT). Semler Scientific has a revolutionary new device with high accuracy and low cost that can change the diagnostic industry. LeMaitre Vascular's unique business model allows it to deliver consistent growth for investors. Fulgent Genetics does genetic testing to diagnose or rule out genetic conditions.
We take a look at their past performance and how they are poised to grow in the future and why we want to recommend them to you. At the end of the podcast, we take on some of the listeners' questions and feedback.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.